Find a trial

ANZadapt / ANZUP 2101

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Locations Adelaide

Diagnosis Prostate cancer

KLK2-comPAS / 78278343PCR3001

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Locations Adelaide

Diagnosis Prostate cancer

LIBERATE

Clinical registry of focal low dose rate brachytherapy in men with biopsy confirmed low-intermediate risk prostate cancer

Locations Epworth Richmond, Epworth Freemasons, Mulgrave, Holmesglen, Geelong, Midland, Rockingham

Diagnosis Prostate cancer

HRS-5041-103

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Locations South Brisbane

Diagnosis Prostate cancer

EvoPAR-Prostate01 / D9723C00001

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents

Locations Chermside, Adelaide

Diagnosis Prostate cancer